Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network.

Burnett-Hartman AN, Powers JD, Chubak J, Corley DA, Ghai NR, McMullen CK, Pawloski PA, Sterrett AT, Feigelson HS.

Cancer Causes Control. 2019 Jul;30(7):747-755. doi: 10.1007/s10552-019-01181-3. Epub 2019 May 17.

PMID:
31102084
2.

The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine.

Rahm AK, Ladd I, Burnett-Hartman AN, Epstein MM, Lowery JT, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Hunter JE.

EGEMS (Wash DC). 2019 Apr 12;7(1):16. doi: 10.5334/egems.283.

3.

Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients.

Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):996-999. doi: 10.1158/1055-9965.EPI-18-1324. Epub 2019 Apr 9.

PMID:
30967418
4.

Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study.

Bowles EJA, Yu O, Ziebell R, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Boggs JM, Burnett-Hartman AN, Sterrett A, Fujii M, Chubak J.

BMC Cancer. 2019 Mar 27;19(1):270. doi: 10.1186/s12885-019-5493-8.

5.

Risk interval analysis of emergency room visits following colonoscopy in patients with inflammatory bowel disease.

Burnett-Hartman AN, Hua X, Rue TC, Golchin N, Kessler L, Rowhani-Rahbar A.

PLoS One. 2019 Jan 9;14(1):e0210262. doi: 10.1371/journal.pone.0210262. eCollection 2019.

6.

Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.

Rahm AK, Cragun D, Hunter JE, Epstein MM, Lowery J, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Burnett-Hartman AN, Gudgeon JM, Hao J, Snyder S, Gogoi R, Ladd I, Williams MS.

BMC Health Serv Res. 2018 Oct 30;18(1):824. doi: 10.1186/s12913-018-3636-2.

7.

Risk of colon cancer recurrence in relation to diabetes.

Chubak J, Yu O, Ziebell RA, Bowles EJA, Sterrett AT, Fujii MM, Boggs JM, Burnett-Hartman AN, Boudreau DM, Chen L, Floyd JS, Ritzwoller DP, Hubbard RA.

Cancer Causes Control. 2018 Nov;29(11):1093-1103. doi: 10.1007/s10552-018-1083-3. Epub 2018 Sep 22.

PMID:
30244297
8.

Telomere length differences between colorectal polyp subtypes: a colonoscopy-based case-control study.

Hardikar S, Burnett-Hartman AN, Phipps AI, Upton MP, Zhu LC, Newcomb PA.

BMC Cancer. 2018 May 2;18(1):513. doi: 10.1186/s12885-018-4426-2.

9.

Indian Health Service Care System and Cancer Stage in American Indians and Alaska Natives.

Burnett-Hartman AN, Adams SV, Bansal A, McDougall JA, Cohen SA, Karnopp A, Warren-Mears V, Ramsey SD.

J Health Care Poor Underserved. 2018;29(1):245-252. doi: 10.1353/hpu.2018.0017.

PMID:
29503298
10.

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA.

J Clin Oncol. 2017 Aug 20;35(24):2806-2813. doi: 10.1200/JCO.2017.72.3569. Epub 2017 Jun 15.

11.

Cancer Treatment Delays in American Indians and Alaska Natives Enrolled in Medicare.

Adams SV, Bansal A, Burnett-Hartman AN, Cohen SA, Karnopp A, Warren-Mears V, Ramsey SD.

J Health Care Poor Underserved. 2017;28(1):350-361. doi: 10.1353/hpu.2017.0027.

PMID:
28239006
12.

Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State.

Hardikar S, Burnett-Hartman AN, Chubak J, Upton MP, Zhu LC, Potter JD, Newcomb PA.

Cancer Causes Control. 2017 Mar;28(3):241-246. doi: 10.1007/s10552-017-0866-2. Epub 2017 Feb 15.

13.

Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems.

Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA; PROSPR Consortium.

Am J Prev Med. 2016 Oct;51(4):e107-15. doi: 10.1016/j.amepre.2016.02.025. Epub 2016 Apr 1.

14.

Cancer Stage in American Indians and Alaska Natives Enrolled in Medicaid.

Adams SV, Burnett-Hartman AN, Karnopp A, Bansal A, Cohen SA, Warren-Mears V, Ramsey SD.

Am J Prev Med. 2016 Sep;51(3):368-72. doi: 10.1016/j.amepre.2016.02.016. Epub 2016 Mar 24.

15.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470.

16.

Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.

Colombara DV, Hughes JP, Burnett-Hartman AN, Hawes SE, Galloway DA, Schwartz SM, Bostick RM, Potter JD, Manhart LE.

J Immunol Methods. 2015 Oct;425:45-50. doi: 10.1016/j.jim.2015.06.007. Epub 2015 Jun 11.

17.

Cancer-Directed Therapy and Hospice Care for Metastatic Cancer in American Indians and Alaska Natives.

Shiovitz S, Bansal A, Burnett-Hartman AN, Karnopp A, Adams SV, Warren-Mears V, Ramsey SD.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1138-43. doi: 10.1158/1055-9965.EPI-15-0251. Epub 2015 May 18.

18.

Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Potter JD, Upton MP, Zhu LC, Rosenfeld ME, Schwartz SM, Rutter CM.

Cancer Causes Control. 2015 Mar;26(3):467-73. doi: 10.1007/s10552-015-0526-3. Epub 2015 Jan 25.

19.

Rare circulating microRNAs as biomarkers of colorectal neoplasia.

Adams SV, Newcomb PA, Burnett-Hartman AN, Wurscher MA, Mandelson M, Upton MP, Zhu LC, Potter JD, Makar KW.

PLoS One. 2014 Oct 6;9(10):e108668. doi: 10.1371/journal.pone.0108668. eCollection 2014.

20.

Association between molecular subtypes of colorectal cancer and patient survival.

Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, Newcomb PA.

Gastroenterology. 2015 Jan;148(1):77-87.e2. doi: 10.1053/j.gastro.2014.09.038. Epub 2014 Sep 30.

21.

Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.

Shiovitz S, Copeland WK, Passarelli MN, Burnett-Hartman AN, Grady WM, Potter JD, Gallinger S, Buchanan DD, Rosty C, Win AK, Jenkins M, Thibodeau SN, Haile R, Baron JA, Marchand LL, Newcomb PA, Lindor NM; Colon Cancer Family Registry.

Br J Cancer. 2014 Jul 29;111(3):598-602. doi: 10.1038/bjc.2014.309. Epub 2014 Jun 10.

22.

Variation in the association between colorectal cancer susceptibility loci and colorectal polyps by polyp type.

Burnett-Hartman AN, Newcomb PA, Hutter CM, Peters U, Passarelli MN, Schwartz MR, Upton MP, Zhu LC, Potter JD, Makar KW.

Am J Epidemiol. 2014 Jul 15;180(2):223-32. doi: 10.1093/aje/kwu114. Epub 2014 May 29.

23.

Access to the Indian health service care system is not associated with early enrollment in medicaid for American Indian and Alaska Natives with cancer.

Burnett-Hartman AN, Bensink ME, Berry K, Mummy DG, Warren-Mears V, Korenbrot C, Ramsey SD.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):362-4. doi: 10.1158/1055-9965.EPI-13-1099. Epub 2013 Dec 2.

24.

Gut microbes, diet, and cancer.

Hullar MA, Burnett-Hartman AN, Lampe JW.

Cancer Treat Res. 2014;159:377-99. doi: 10.1007/978-3-642-38007-5_22. Review.

25.

No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.

Passarelli MN, Newcomb PA, Makar KW, Burnett-Hartman AN, Phipps AI, David SP, Hsu L, Harrison TA, Hutter CM, Duggan DJ, White E, Chan AT, Peters U.

Menopause. 2014 Apr;21(4):415-20. doi: 10.1097/GME.0b013e31829e498d.

26.

Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, Grady WM, Zhu LC, Upton MP, Makar KW.

Cancer Res. 2013 May 1;73(9):2863-72. doi: 10.1158/0008-5472.CAN-12-3462. Epub 2013 Mar 28.

27.

Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Burnett-Hartman AN, Passarelli MN, Adams SV, Upton MP, Zhu LC, Potter JD, Newcomb PA.

Am J Epidemiol. 2013 Apr 1;177(7):625-37. doi: 10.1093/aje/kws282. Epub 2013 Mar 3.

28.

Human papillomavirus DNA is rarely detected in colorectal carcinomas and not associated with microsatellite instability: the Seattle colon cancer family registry.

Burnett-Hartman AN, Feng Q, Popov V, Kalidindi A, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):317-9. doi: 10.1158/1055-9965.EPI-12-1170. Epub 2012 Dec 18.

29.

BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics.

Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1792-8. doi: 10.1158/1055-9965.EPI-12-0674. Epub 2012 Aug 16.

30.

No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study.

Burnett-Hartman AN, Newcomb PA, Schwartz SM, Bostick RM, Pawlita M, Waterboer T, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1599-601. doi: 10.1158/1055-9965.EPI-12-0651. Epub 2012 Jun 26.

31.

Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer.

Burnett-Hartman AN, Newcomb PA, Phipps AI, Passarelli MN, Grady WM, Upton MP, Zhu LC, Potter JD.

Am J Gastroenterol. 2012 Aug;107(8):1213-9. doi: 10.1038/ajg.2012.167. Epub 2012 Jun 12.

32.

Telomere-associated polymorphisms correlate with cardiovascular disease mortality in Caucasian women: the Cardiovascular Health Study.

Burnett-Hartman AN, Fitzpatrick AL, Kronmal RA, Psaty BM, Jenny NS, Bis JC, Tracy RP, Kimura M, Aviv A.

Mech Ageing Dev. 2012 May;133(5):275-81. doi: 10.1016/j.mad.2012.03.002. Epub 2012 Mar 16.

33.

No evidence for human papillomavirus in the etiology of colorectal polyps.

Burnett-Hartman AN, Newcomb PA, Mandelson MT, Galloway DA, Madeleine MM, Wurscher MA, Carter JJ, Makar KW, Potter JD, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2288-97. doi: 10.1158/1055-9965.EPI-11-0450. Epub 2011 Aug 4.

34.

Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms.

Burnett-Hartman AN, Newcomb PA, Mandelson MT, Adams SV, Wernli KJ, Shadman M, Wurscher MA, Makar KW.

Nutr Cancer. 2011;63(4):583-92. doi: 10.1080/01635581.2011.553021.

35.

Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps.

Adams SV, Newcomb PA, Burnett-Hartman AN, White E, Mandelson MT, Potter JD.

Nutr Cancer. 2011;63(3):319-26. doi: 10.1080/01635581.2011.535960.

36.

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM.

Gut. 2011 Apr;60(4):491-8. doi: 10.1136/gut.2010.221143. Epub 2010 Nov 4.

37.

Multivitamin supplement use and risk of invasive breast cancer.

Meulepas JM, Newcomb PA, Burnett-Hartman AN, Hampton JM, Trentham-Dietz A.

Public Health Nutr. 2010 Oct;13(10):1540-5. doi: 10.1017/S1368980009992187. Epub 2009 Dec 3.

38.

Supplement use contributes to meeting recommended dietary intakes for calcium, magnesium, and vitamin C in four ethnicities of middle-aged and older Americans: the Multi-Ethnic Study of Atherosclerosis.

Burnett-Hartman AN, Fitzpatrick AL, Gao K, Jackson SA, Schreiner PJ.

J Am Diet Assoc. 2009 Mar;109(3):422-9. doi: 10.1016/j.jada.2008.11.023.

39.

Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Burnett-Hartman AN, Newcomb PA, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2970-9. doi: 10.1158/1055-9965.EPI-08-0571. Review.

Supplemental Content

Loading ...
Support Center